Background: Premenstrual Dysphoric Disorder (PMDD) is a severe and disabling form of premenstrual syndrome (PMS) affecting 3-8% of women. PMDD was added to the list of depressive disorders in the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) in 2013.
Introduction
Premenstrual dysphoric disorder (PMDD) is a diagnosis used to indicate serious premenstrual distress associated with deterioration in functioning (1) . PMDD affects 3-8% of women worldwide in their reproductive years (2) . From the clinical point of view significant premenstrual problems with mood and behavioral changes have been recorded since ancient times (1) . Most women in their reproductive age experience one or more mild emotional, psychogenic or physical symptoms for one to two days before the onset of menses. These symptoms, such as breast soreness and bloating, are mild, do not cause severe distress or functional impairment, and are not considered to represent premenstrual syndrome (PMS) (3) . Up to eighty percent of women report one or more physical, psychological, or behavioral symptoms during the luteal phase of their menstrual cycle without experiencing substantial disruption to their daily activities. Mild to moderate symptoms of PMS that affect some facet of the woman's life, occurs in 20 to 32 percent of premenopausal women, however, the more severe symptoms of PMDD affect 3 to 8 percent of premenopausal women (3).
The etiology of PMDD is still an active area of research. While the timing of symptoms suggests a hormonal fluctuation as the cause of PMDD, a demonstrable hormonal imbalance in women with PMDD has not been identified. In fact, levels of reproductive hormones in women with and without PMDD are indistinguishable (4).
PMDD is a severe form of premenstrual syndrome. Like PMS, PMDD follows a predictable, cyclic pattern. Symptoms begin in the late luteal phase of the menstrual cycle (after ovulation) and end shortly after menstruation begins (5). On average, the symptoms last six days but can start up to two weeks before menses. The most intense symptoms occur two days before and one day after the start of menstrual blood flow, and cease shortly after the start of menses (6) . PMDD have both physical and emotional symptoms. The most debilitating symptoms are emotional and include "irritability, depression, mood lability, anxiety, feelings of 'loss of control', difficulty concentrating and fatigue."(7)
The physical symptoms include "abdominal bloating, breast tenderness, headache and generalized aches" (8) . Marked lability (e.g., mood swings), marked irritability or anger, markedly depressed mood, marked anxiety and tension, decreased interest in usual activities, difficulty in concentration, lethargy and marked lack of energy, marked change in appetite (e.g., overeating or specific food cravings), hypersomnia or insomnia, feeling overwhelmed or out of control and physical symptoms (e.g., breast tenderness or swelling, joint or muscle pain, a sensation of 'bloating' and weight gain). According to the DSM-V, a diagnosis of PMDD requires the presence of at least five of these symptoms with one of the symptoms being one of (marked lability, irritability, depressed mood or anxiety and tension). These symptoms should occur during the week before menses and remit after initiation of menstrual blood flow. In order to meet criteria for the diagnosis, the symptoms should be charted prospectively for two consecutive ovulation cycles in order to confirm temporal and cyclical nature of symptoms. The symptoms should also be severe enough to affect normal work, school, or social activities or relationships with others (9).
Management of premenstrual dysphoric disorder (PMDD) includes both non-pharmacologic and pharmacologic therapies. Non-pharmacologic therapy includes aerobic exercise, consumption of complex carbohydrates and frequent meals, relaxation training, light therapy, sleep deprivation, and cognitive-behavioral therapy (CBT). The efficacy of lifestyle interventions (e.g. diet, exercise, and vitamin supplementation) and psychotherapeutic interventions for PMDD remains unclear (3, 9) .
Methodology
This was a cross-section study, conducted on female medical students of UQU, Makkah Al-Mukaramah, KSA during the academic year 2013/2014. A multistage stratified systematic random sampling technique was used to select the participants. Out of all faculty students 183 were selected according to the following inclusion and exclusion criteria.
Inclusion criteria: All medical menstruating female students
Exclusion criteria: Currently pregnant students, chronic illnesses (e.g. diabetes, hypertension), psychiatric disorders such as depression, anxiety, currently using hormonal contraceptives, Intern medical students and those who had an irregular menstrual cycle.
A semi-structured, self-administered questionnaire was used for data collection. The questionnaire included demographic data and possible symptoms of PMS according to DSM -V. A pilot study was done on 19 (10% of the calculated sample size) female students to assess its validity, highlight problems associated with data collection tools, and to ensure standardization. The criteria proposed by DSM -V were used to diagnose PMDD. Symptoms must have been present in most of menstrual cycles of the previous year, and must be associated with significant distress or interference with the usual activities (e.g. school, social life).
The study was conducted after getting ethical approval from the ethical committee of the Faculty of medicine. Participation was voluntary and non-obligation was offered. A written consent was taken from the participants after explanations of the objectives and methodology of the study. The participants were told that, their information will be kept with complete confidentiality and there would be no attempt to abuse their information.
Data Analysis
Data were analyzed using SPSS version 20. Descriptive analytical parameters were used to summarize the sociodemographic and clinical characteristics of the study participants. Summary tables and graph were used for descriptive purpose. The different socio-demographic, gynecologic and obstetric characteristics variables were presented, compared, analyzed and frequency distributions of the variables were interpreted. Chi-square test was used to assess the association of different factors with the PMS. A p-value less than 0.05 was considered significant.
Results

Figure 1: Prevalence of premenstrual dysphoric disorder among medical students of umm Al-Qura university
The study was carried out on female medical students of UQU (183). Their age ranged from 18 to 25 years, with mean age of 19.66 ± 3.92. Their socio-demographic data showed that most of them were single (90.8%) and 8.7 % were married, however 0.5 % were divorced. The prevalence of PMDD was 36.5%. There was no significant difference between students with PMDD and without regarding physical symptoms. Lack of energy, easy fatigability and lethargy are the most prevalent symptoms (81.9%). 29.6% experienced joint or muscle pain, 58.5 % complained of breast tenderness or swelling and 63.9% suffered from headache. There was no significance between students with PMDD and without regarding demographic characteristics and physical symptoms.
Discussion
PMDD is a multifactorial syndrome that occurs with varying degrees of severity and thus may have a range of potential adverse effects on workability, social activities and interpersonal relationships. Epidemiologic studies indicate that as many as 80% of women in the United States experience emotional, behavioral, or physical premenstrual symptoms (11) . Unfortunately, there are no national studies to determine the epidemiological features of PMDD among the university students at Umm Al-Qura University so this cross sectional study was conducted to clarify the burden of problem among the medical students. In the current study the prevalence of PMDD among female medical students who met DSM-V criteria was 36.6 % which is higher than most of the previous studies on the general population, for example, a study done by Cohen et al. (12) reported that, in women aged 36-44 years the prevalence of PMDD was 6.4% (12) . Also a study by RiveraTovar and Frank (13) showed that, 4.6% of 217 female university students had PMDD. A study done by Steiner et al. (14) on girls in the age group of 12-18 years showed a prevalence of premenstrual symptoms to be 8.3%; however a study conducted in Pakistan among young college girls reported a slightly higher prevalence as 18.2% (15) .
Also prevalence values of 17.2% and 18.2% were obtained also in Nigeria (16) and Croatia (17) respectively. Also a very recent Indian study (18) revealed that prevalence of PMDD was 12.22%. 
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MIDDLE EAST JOURNAL OF FAMILY MEDICINE VOLUME 14 ISSUE 2, MARCH 2016 Table 2 : Duration of symptoms of PMDD among medical students of umm Al-Qura university The prevalence of the current study was in accordance with the prevalence of studies done by Issa et al. (7) and Serfaty et al. (19) who reported prevalence of 36.1% and 35% respectively. Theses variations may be due to oral contraceptive pills that reduce the severity and frequency of the symptoms of PMDD (20) . It can also attribute to different cultural and socioeconomic background, diagnostic criteria and confusion of participants regarding their physical and emotional symptoms. The reason for the high prevalence rate of PMDD among participants of the current study may be due to stress related learning or can be justifiable by the fact that the vast majority of participants are single. In this study there was no significant difference between students with PMDD and without regarding physical symptoms which is not in agreement with a study by Brahmbhatt et al. (21) who reported that, the overall frequency of somatic complaints was more than that of the abnormal mood and behavior.
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MIDDLE EAST JOURNAL OF FAMILY MEDICINE VOLUME 14 ISSUE 2, MARCH 2016 In the current study, lack of energy, easy fatigability and lethargy are the most prevalent symptoms (81.9%) in contrast to the results of Minakshi et al., (22) who reported marked persistent irritability as the most frequent (96.29%) symptom. However the mood swings came second in frequency (76.5%) which is in agreement with the results of a study by Minakshi et al. (22) . A study in Ethiopia reported that, the most common psycho-behavioral symptoms experienced by the participants were loss of interest in doing things (77.5%), followed by depressed mood (74.6%), anger feeling (57.2%), and lack of concentration (46.8%) (23).
In the current study 29.6% experienced joint or muscle pain, 58.5 % complained of breast tenderness or swelling and 63.9% suffered from headache. This was in accordance with the Ethiopian study that reported physical symptoms as follows, breast tenderness by (68.2%), back pain by (66.5%), weakness by (61.9%), generalized body pain by (60.1%), and headache by (57.8%) of the participants (23).
All of the PMDD patients in the current study confirmed that the symptoms have significant impact on their academic performance, social activities and engagement based on DSM-V criteria for diagnosis of PMDD. Borenstein et al. (24) reported that women diagnosed with PMDD have significantly lower quality of life, increased absenteeism from work, decreased work productivity, impaired relationships with others and increased visits to health providers, compared with control women. In the present study there was no significance between students with PMDD and without regarding demographic characteristics and physical symptoms while there was a high significance regarding most of the mood and behavior parameters.
Conclusion
PMDD has more or less a high prevalence rate among medical students of UQU which necessitates more effort for early detection, and management to ensure continuity of care for their general welfare, better health and life quality as well as better scholastic achievement.
